Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
A Paradigm Change in the Treatment Strategy for Hepatocellular CarcinomaKudo, MasatoshiLiver cancer (Basel ), 2020-08, Vol.9 (4), p.367-377 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
2 |
Material Type: Artigo
|
Adjuvant Immunotherapy after Curative Treatment for Hepatocellular CarcinomaKudo, MasatoshiLiver cancer (Basel ), 2021-09, Vol.10 (5), p.399-403 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
3 |
Material Type: Artigo
|
Cabozantinib as a Second-Line Agent in Advanced Hepatocellular CarcinomaKudo, MasatoshiLiver cancer (Basel ), 2018-05, Vol.7 (2), p.123-133 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
4 |
Material Type: Artigo
|
Combination Cancer Immunotherapy in Hepatocellular CarcinomaKudo, MasatoshiLiver cancer (Basel ), 2018-03, Vol.7 (1), p.20-27 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
5 |
Material Type: Artigo
|
Early Hepatocellular Carcinoma: Definition and DiagnosisKudo, MLiver cancer (Basel ), 2013-04, Vol.2 (2), p.69-72 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
6 |
Material Type: Artigo
|
Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular CarcinomaKudo, MasatoshiLiver cancer (Basel ), 2018-09, Vol.7 (3), p.215-224 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
7 |
Material Type: Artigo
|
Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage BKudo, MLiver cancer (Basel ), 2016-04, Vol.5 (2), p.91-96 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
8 |
Material Type: Artigo
|
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing TrialsKudo, MasatoshiLiver cancer (Basel ), 2019-07, Vol.8 (4), p.221-238 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
9 |
Material Type: Artigo
|
Japan’s Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global SurveillanceKudo, MLiver cancer (Basel ), 2012-11, Vol.1 (3-4), p.141-143 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |
|
10 |
Material Type: Artigo
|
Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular CarcinomaKudo, MasatoshiLiver cancer (Basel ), 2018-03, Vol.7 (1), p.1-19 [Periódico revisado por pares]Basel, Switzerland: S. Karger AGTexto completo disponível |